Dirk Huebner
Directeur Technique/Scientifique/R&D chez APTEVO THERAPEUTICS INC.
Postes actifs de Dirk Huebner
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| APTEVO THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Dirk Huebner
Anciens postes connus de Dirk Huebner
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MERSANA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 27/11/2018 | 30/11/2020 |
Boston Biomedical, Inc.
 Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Corporate Officer/Principal | 01/08/2017 | 01/11/2018 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/08/2017 | 01/08/2017 |
Formation de Dirk Huebner
| Freie Universität Berlin | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Allemagne | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MERSANA THERAPEUTICS, INC. | Health Technology |
| APTEVO THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Boston Biomedical, Inc.
Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Commercial Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Dirk Huebner
- Expérience
